Mankind Pharma’s Strategic Leap: Acquiring Bharat Serums and Vaccines
Mankind Pharma’s Strategic Leap: Acquiring Bharat Serums and Vaccines In a major development for the Indian pharmaceutical industry, Mankind Pharma has successfully clinched a deal to acquire Bharat Serums and Vaccines Limited (BSV). The acquisition, valued at approximately ₹13,630 crore (around $1.64 billion), positions Mankind Pharma as a key player in critical healthcare segments and … Read more